ИССЛЕДОВАНИЕ АВТОНОМНОЙ СТАБИЛЬНОСТИ SH3-ДОМЕНА

1. Teyra, J., Huang, H., Jain, S., Guan, X., Dong, A., et al. Comprehensive Analysis of the Human SH3 Domain Family Reveals a Wide Variety of Non-Canonical Specificities. Structure 2017, 25 (10), 1598-1610.e3. https://doi.org/10.1016/j.str.2017.07.017.

2. Morton, C.J., Campbell, I.D. SH3 Domains. Molecular "Velcro." Curr Biol 1994, 4 (7), 615-617. https://doi.org/10.1016/s0960- 9822(00)00134-2.

3. Schlessinger, J. SH2/SH3 Signaling Proteins. Current Opinion in Genetics & Development 1994, 4 (1), 25-30. https://doi.org/10.1016/0959-437X(94)90087-6.

4. Koch, C.A., Anderson, D., Moran, M.F., Ellis, C., Pawson, T. SH2 and SH3 Domains: Elements That Control Interactions of Cytoplasmic Signaling Proteins. Science 1991, 252(5006), 668-674. https://doi.org/10.1126/science.1708916.

5. Kishan, K.V., Agrawal V. SH3-like fold proteins are structurally conserved and functionally divergent. Curr Protein Pept Sci. 2005. 6(2):143-50. doi: 10.2174/1389203053545444.

6. Horn Anselm, H.C., Sticht Heinrich. Synthetic Protein Scaffolds Based on Peptide Motifs and Cognate Adaptor Domains for Improving Metabolic Productivity. Frontiers in Bioengineering and Biotechnology 2015. 3, 2296-4185. https://doi.org/10.3389/fbioe.2015.00191.

7. Grabulovski, D, Kaspar, M, Neri, D. A novel, non-immunogenic Fyn SH3-derived binding protein with tumor vascular targeting properties. The Journal of Biological Chemistry. 2007. 282(5):3196-3204. doi: 10.1074/jbc.m609211200.

8. Elizabeth, Pham, Kevin, Truong. Engineered regulation of lysozyme by the SH3-CB1 binding interaction. Protein Engineering, Design and Selection. 2012. 25(6): 307-311, https://doi.org/10.1093/protein/gzs020.

9. Nikolsky, K.S. et al. Three-helix bundle and SH3-type barrels: autonomously stable structural motifs in small and large proteins. Journal of Biomolecular Structure and Dynamics. 2023. https://doi.org/10.1080/07391102.2023.2250450.